Alx Oncology Holdings (ALXO) Total Current Liabilities (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Total Current Liabilities data on file, last reported at $20.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 7.66% year-over-year to $20.2 million; the trailing twelve-month figure through Mar 2026 stood at $20.2 million (up 7.66% YoY), and the FY2025 full-year result was $24.6 million, up 32.72% from the prior year.
• Total Current Liabilities declined to $20.2 million in Q1 2026, from $24.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $38.4 million in Q2 2024 to a low of $15.3 million in Q1 2022.
• A 5-year average of $25.6 million and a median of $24.6 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 118.81% in 2024 and plunged 50.98% in 2025, its largest moves.
• Tracing ALXO's Total Current Liabilities over 5 years: stood at $28.3 million in 2022, then increased by 27.1% to $36.0 million in 2023, then sank by 48.61% to $18.5 million in 2024, then surged by 32.72% to $24.6 million in 2025, then dropped by 17.82% to $20.2 million in 2026.
• Business Quant data shows ALXO's Total Current Liabilities at $20.2 million in Q1 2026, $24.6 million in Q4 2025, and $27.7 million in Q3 2025.